148 related articles for article (PubMed ID: 3732046)
1. Ethics and errors of clinical trials and the role and place of different types of trial.
Mathé G; Reizenstein P
Drugs Exp Clin Res; 1986; 12(1-3):1-9. PubMed ID: 3732046
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of and errors in randomized multicenter trials. A review of 230 clinical trials.
Reizenstein P; Delgado M; Gastiaburu J; Lomme L; Ogier C; Pals H; Schellekens J; Whittaker J; Mathé G
Biomed Pharmacother; 1983; 37(1):14-24. PubMed ID: 6616027
[TBL] [Abstract][Full Text] [Related]
3. Optimising the design of phase II oncology trials: the importance of randomisation.
Ratain MJ; Sargent DJ
Eur J Cancer; 2009 Jan; 45(2):275-80. PubMed ID: 19059773
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials symposium. Highlights in development of randomized clinical trials.
Forbes JF
Med J Aust; 1981 Feb; 1(4):159-60. PubMed ID: 6939955
[TBL] [Abstract][Full Text] [Related]
5. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
6. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
7. Phase I cancer trials: limitations and implications.
Dillman RO; Koziol JA
Mol Biother; 1992 Sep; 4(3):117-21. PubMed ID: 1445664
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
Bellissant E; Bénichou J; Chastang C
Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
[TBL] [Abstract][Full Text] [Related]
11. [Current status and issues in clinical trials of anticancer agents].
Kojima H
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial design in metastatic breast cancer: a commentary.
Levine M
Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
[TBL] [Abstract][Full Text] [Related]
13. Designs for efficient clinical trials.
Simon R
Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
[TBL] [Abstract][Full Text] [Related]
14. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
Taylor JM; Braun TM; Li Z
Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
[TBL] [Abstract][Full Text] [Related]
15. Some ethical issues in phase II trials in acute leukemia.
Thall PF; Estey EH
Clin Adv Hematol Oncol; 2005 Dec; 3(12):943-8. PubMed ID: 16555436
[TBL] [Abstract][Full Text] [Related]
16. Optimizing randomized phase II trials assessing tumor progression.
Stone A; Wheeler C; Carroll K; Barge A
Contemp Clin Trials; 2007 Feb; 28(2):146-52. PubMed ID: 16807129
[TBL] [Abstract][Full Text] [Related]
17. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
18. [A tentative of guideline for phase III study and its problems in clinical aspect].
Nakao I
Gan To Kagaku Ryoho; 1984 Mar; 11(3):395-403. PubMed ID: 6703719
[TBL] [Abstract][Full Text] [Related]
19. Types of clinical caries studies: epidemiological surveys, randomized clinical trials, and demonstration programs.
Stamm JW
J Dent Res; 1984 May; 63 Spec No():701-8. PubMed ID: 6373865
[TBL] [Abstract][Full Text] [Related]
20. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues.
Shuster JJ; Krischer JP; Boyett JM
Am J Pediatr Hematol Oncol; 1985; 7(1):64-70. PubMed ID: 4037245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
